Melatonin and the skin: From frog to human

International Journal of Dermatology

Volumn 35, Issue 10, 1996, Pages 695-697

  Cohn, Bruce A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

HUMAN; MELANOMA; PINEAL BODY; REVIEW; SKIN PIGMENTATION;

EID: 0029857244     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb00638.x     Document Type: Review

References (34)

1. Waldhauser F, Frisch H, Waldhauser M, et al. Fall in nocturnal serum melatonin during puberty and pubescence. Lancet 1984; i:362-365.
2. Waldhauser F, Weiszenbacher G, Tatzer E, et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metah 1988; 66:648-652.
3. Cavallo A. Plasma melatonin rhythm in normal puberty: interactions of age and pubertal stages. Neuroendocrinology 1992; 55:372-379.
4. Turek FW. Melatonin hype hard to swallow. Nature 1996; 379:295-296.
5. Rust CC, Meyer RK. Hair color, molt, and testis size in male, short-tailed weasels treated with melatonin. Science 1969; 165:921-922.
6. Maietta G, Rongioletti F, Rebora A. Seborrheic dermatitis and daylight. Acta Derm Venereol (Stockh) 1991; 71:538-539.
7. Schwarz W, Birau N, Hornstein OP, et al. Alterations of melatonin secretion in atopic eczema. Acta Derm Venereol (Stockh) 1988; 68:224-229.
8. Mozzanica N, Tadini G, Radaelli A, et al. Plasma melatonin levels in psoriasis. Acta Derm Venereol (Stockh) 1988; 68:312-316.
9. Lerner AB, Case JD, Takahashi Y, et al. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 1958; 80:2587.
10. Wright MR, Lerner AB. On the movement of pigment granules in frog melanocytes. Endocrinology 1960; 66: 599-609.
11. Abe K, Robison GA, Liddle GW, et al. Role of cyclic AMP in mediating the effects of MSH, norepinephrine, and melatonin on frog skin color. Endocrinology 1969; 85:674-682.
12. Utiger RD. Melatonin - the hormone of darkness. N Eng J Med 1992; 327:1377-1379. [Editorial]
13. Logan A, Weatherhead B. Post-tyrosinase inhibition of melanogenesis by melatonin in hair follicles in vitro. J Invest Dermatol 1980; 74:47-50.
14. Weatherhead B, Logan A. Interaction of alpha-melanocyte-stimulating hormone, melatonin, cyclic AMP and cyclic GMP in the control of melanogenesis in hair follicle melanocytes in vitro. J Endocrinol 1981; 90: 89-96.
15. Snell RS. Effect of melatonin on mammalian epidermal melanocytes. J Invest Dermatol 1965; 44:273-275.
16. McGuire J, Möller H. Differential responsiveness of dermal and epidermal melanocytes of Rana pipiens to hormones. Endocrinology 1966; 78:367-372.
17. Waldhauser F, Waldhauser M, Lieberman HR, et al. Bioavailability of oral melatonin in humans. Neuroendocrinology 1984; 39:307-313.
18. McElhinney DB, Hoffman SJ, Robinson WA, et al. Effect of melatonin on human skin color. J Invest Dermatol 1994; 102:258-259.
19. Nordlund JJ, Lerner AB. The effects of oral melatonin on skin color and on the release of pituitary hormones. J Clin Endocrinol Metab 1977; 45:768-774.
20. Hunt G, Todd C, Kyne S, et al. ACTH stimulates melanogenesis in cultured human melanocytes. J Endocrinol 1994; 140:R1-R3.
21. Gonzalez R, Sanchez A, Ferguson JA, et al. Melatonin therapy of advanced human malignant melanoma. Melanoma Res 1991; 1:237-243.
22. Feuer G. Biochemistry of the pineal gland as an endocrine organ. Drug Metab Drug Interact 1990; 8:203-246.
23. Kerenyi NA, Pandula E, Feuer GM. Oncostatic effects of the pineal gland. Drug Metab Drug Interact 1990; 8: 313-390.
24. Dogliotti L, Berruti A, Buniva T, et al. Melatonin and human cancer. J Steroid Biochem Mol Biol 1990; 37: 983-987.
25. El-Domeiri AAH, Das Gupta TK. The influence of pineal ablation and administration of melatonin on growth and spread of hamster melanoma. J Surg Oncol 1976; 8:197-205.
26. Narita T, Kudo H. Effect of melatonin on B16 melanoma growth in athymic mice. Cancer Res 1985; 45: 4175-4177.
27. Slominski A, Pruski D. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res 1993; 206:189-194.
28. Ying SW, Niles LP, Crocker C. Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol 1993; 246:89-96.
29. Lerner AB, Shizume K, Bunding I. The mechanism of endocrine control of melanin pigmentation. J Clin Endocrinol Metab 1954; 14:1463-1490.
30. Goldman L, Richfield DF. Effect of corticotropin and cortisone on development and progress of pigmented nevi. JAMA 1951; 147:941-943.
31. Lerner AB, McGuire JS. Effect of alpha- and beta-melanocyte stimulating hormones on the skin colour of man. Nature 1961; 189:176-179.
32. Lerner AB, McGuire JS. Melanocyte-stimulating hormone and adrenocorticotropic hormone - their relation to pigmentation. N Engl J Med 1964; 270:539-546.
33. Levine N, Sheftel SN, Eytan T, et al. Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA 1991; 266:2730-2736.
34. Halpern AC, Guerry IV D, Elder DE, et al. Natural history of dysplastic nevi. J Am Acad Dermatol 1993; 29:51-57.